U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07513571) titled 'A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults' on March 31.
Brief Summary: The purpose this study is to measure the impact of laroprovstat (AZD0780) on the pharmacokinetics (PK) of AZD4954 and the impact of AZD4954 on the PK of laroprovstat in healthy male and female participants.
Study Start Date: April 10
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: AZD4954
AZD4954 will be administered orally.
DRUG: Laroprovstat
Laroprovstat will be administered orally.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Published by...